• Product NameTFPI LACI Antibody FITC Conjugated
• Host SpeciesRabbit
• ClonalityPolyclonal
• IsotypeIgG
• PurificationPurified by Protein A.
• ApplicationsIF
• Species ReactivityHu Ms Rt
• Immunogen DescriptionKLH conjugated synthetic peptide aa 130-180 304 derived from human TFPI
• ConjugatesFITC
• Excitation Emission494nm 518nm
• Target NameTFPI LACI
• Alternative Names    EPI; TFI; LACI; TFPI1; Tissue factor pathway inhibitor; TFPI; Extrinsic pathway inhibitor; Lipoprotein-associated coagulation inhibitor
• Accession No. Swiss-Prot#P10646
  NCBI Gene ID7035
• UniprotP10646
• Gene ID7035;
• Cell Localization Secreted, Membrane bound
• Concentration 1mg ml
• Formulation 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
• Storage Shipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.

• IF=1:50-200

Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa tissue factor activity, presumably by forming a quaternary Xa LACI VIIa TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting